Diabetes

Hand holding Bigfoot rapid-acting smart insulin pen
By  Mallory Hackett 11:58 am May 10, 2021
This morning, Bigfoot Biomedical announced it has received FDA 510(k) clearance for its Bigfoot Unity Diabetes Management System. The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes who use multiple-dose injection therapy. Included in the Bigfoot Unity System are two smartpen caps for both rapid- and long-acting insulin, a connected mobile app, an...
Shaking Hands
By  Mallory Hackett 11:26 am May 6, 2021
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products. The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche. Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
GluCare, diabetes, continuous data monitoring, wearable, diabetes management
By  Rachel McArthur 05:41 am April 22, 2021
A Dubai-based specialist diabetes clinic has released its very first report on the outcomes of its care model, demonstrating that continuous data monitoring is advantageous in dramatically improving the health of those with the condition. GluCare Integrated Diabetes Center, which describes itself as the “world’s first healthcare provider to employ integrated continuous data monitoring” and the “...
Screenshots of Dongwoon Anatech's blood glucose monitoring device.
By  Thiru Gunasegaran 02:40 am April 12, 2021
South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December. WHAT IT DOES The glucose monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent...
Images of the Glooko app and a family
By  Dave Muoio 03:04 pm March 16, 2021
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise. WHAT IT DOES The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
A product shot of Upright's digital MSK offering.
By  Dave Muoio 02:01 pm January 27, 2021
DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) health company that specializes in connected posture correction devices and digital coaching. The deal is expected to close on or around February 7, and will run DarioHealth $31 million to complete the...
More than 11 million Canadians live with diabetes or prediabetes, making up 29% of the country’s population.
By  Mallory Hackett 11:47 am December 2, 2020
Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes. The FreeStyle Libre 2 system continuously measures glucose data every minute and can automatically alert users when their glucose is high or low without needing to scan the sensor. It is worn on the back of the user’s upper arm for up to 14...
An image of the pre-acquisition InPen device and connected app.
By  Dave Muoio 01:56 pm November 12, 2020
Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) system. Of note, Medtronic's InPen is the only smart insulin pen cleared by the FDA for use by people requiring multiple daily injections. It received that 510(k) back in 2016. WHY IT MATTERS With...
By  Dean Koh 02:57 am November 11, 2020
Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes. The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
Screens and a plate of food
By  Dave Muoio 03:26 pm November 3, 2020
New top-line data presented by Omada Health and researchers from the University of Nebraska Medical Center and Wake Forest University suggest that the chronic condition-management company's digital diabetes-prevention program can deliver clinically meaningful blood sugar reduction and weight loss over 12 months. The PREDICTS randomized controlled trial was first announced in 2018, and enrolled...